RS Research, founded by Prof. Dr. Rana Sanyal and Sena Nomak to advance laboratory research to the clinical stage and deliver it to patients, won the Grand Prix Award at the ISIF’22 Istanbul International Invention Fair held during the TEKNOFEST Aerospace, Space, and Technology Festival in Samsun for their invention “Fragile Polymer Drug Conjugates.” The biotechnology startup RS Research, which discovers smart drugs enabling targeted chemotherapy in oncology, is developing next-generation treatments against cancer.

277 INVENTIONS COMPETED FROM 12 COUNTRIES AT ISIF’22

Within the scope of the TEKNOFEST Space, Aerospace, and Technology Festival, the ISIF'22 International Invention Fair was organized in cooperation with the Ministry of Industry and Technology, the World Intellectual Property Organization (WIPO), the International Federation of Inventors’ Associations (IFIA), the European Patent Office (EPO), and the Turkish Patent and Trademark Office. A total of 277 inventions from 12 countries competed at the event. RS Research won the Grand Prix Award with their invention “Fragile Polymer Drug Conjugates.” Winners received their awards from President Recep Tayyip Erdoğan during the ceremony.

SMART DRUGS TO MAKE CHEMOTHERAPY MORE EFFECTIVE

The biotechnology startup, which develops drug candidates that enhance the effectiveness of chemotherapy while reducing side effects through its proprietary drug delivery technology, strengthens early-stage studies of its drug candidates through collaboration with the Boğaziçi University Center for Life Sciences and Technologies Application and Research Center.

Completing its production infrastructure at its facility in Teknopark Istanbul, RS Research developed Turkey’s first novel drug candidate whose development—from laboratory to clinical trials—has been undertaken domestically and which has entered Phase 1 clinical trials. The Phase 1 clinical trial of the first drug candidate based on the patented targeted carrier technology, intended for lung cancer treatment, is ongoing with patient volunteers in Istanbul and Ankara.